Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study

Tien Nguyen; Melvin Churchill; Robert Levin; Guillermo Valenzuela; Joseph F. Merola; Alexis Ogdie; Ana-Maria Orbai; Jose U. Scher; Arthur Kavanaugh; Farid Kianifard; Chauncy Rollins; Renato Calheiros; Olivier Chambenoit

doi:10.3899/jrheum.210912

Research ArticlePsoriatic Arthritis

Open Access

Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study

Tien Nguyen, Melvin Churchill, Robert Levin, Guillermo Valenzuela, Joseph F. Merola, Alexis Ogdie, Ana-Maria Orbai, Jose U. Scher, Arthur Kavanaugh, Farid Kianifard, Chauncy Rollins, Renato Calheiros and Olivier Chambenoit

The Journal of Rheumatology August 2022, 49 (8) 894-902; DOI: https://doi.org/10.3899/jrheum.210912

Tien Nguyen

1T. Nguyen, MD, First OC Dermatology, Irvine, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Melvin Churchill

2M. Churchill, MD, Arthritis Center of Nebraska, Lincoln, Nebraska;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Melvin Churchill

Robert Levin

3R. Levin, MD, Clinical Research of West Florida, Inc., Clearwater, Florida, and University of South Florida, Tampa, Florida;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Guillermo Valenzuela

4G. Valenzuela, MD, Integral Rheumatology & Immunology Specialists, Plantation, Florida, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joseph F. Merola

5J.F. Merola, MD, Department of Dermatology and Medicine, Division of Rheumatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Joseph F. Merola

Alexis Ogdie

6A. Ogdie, MD, MSCE, Department of Medicine/Rheumatology and Department of Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Alexis Ogdie

Ana-Maria Orbai

7A.M. Orbai, MD, MHS, Division of Rheumatology, Psoriatic Arthritis Program, Johns Hopkins University School of Medicine, Baltimore, Maryland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ana-Maria Orbai

Jose U. Scher

8J.U. Scher, MD, Division of Rheumatology, New York University School of Medicine and NYU Langone Orthopedic Hospital, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Arthur Kavanaugh

9A. Kavanaugh, MD, Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California, San Diego, La Jolla, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Farid Kianifard

10F. Kianifard, PhD, C. Rollins, MS, R. Calheiros, MD, O. Chambenoit, PhD, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Chauncy Rollins

10F. Kianifard, PhD, C. Rollins, MS, R. Calheiros, MD, O. Chambenoit, PhD, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Renato Calheiros

10F. Kianifard, PhD, C. Rollins, MS, R. Calheiros, MD, O. Chambenoit, PhD, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Olivier Chambenoit

10F. Kianifard, PhD, C. Rollins, MS, R. Calheiros, MD, O. Chambenoit, PhD, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
References
PDF

PreviousNext

Data supplements

210912DataSuppl.pdf
210912 Video Abstract

Files in this Data Supplement:

210912 Transcript

PreviousNext

In this issue

The Journal of Rheumatology

Vol. 49, Issue 8

1 Aug 2022

Table of Contents
Table of Contents (PDF)
Index by Author
Editorial Board (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study

Message Subject (Your Name) has forwarded a page to you from The Journal of Rheumatology

Message Body (Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study